Other Events ·
Glaukos Corp filed an 8-K to disclose the availability of its August 2026 Investor Presentation on its investor…
GKOSGLAUKOS Corp
Glaukos Corp filed an 8-K to disclose the availability of its August 2026 Investor Presentation on its investor relations website. The filing contains no material operational updates, financial results, or corporate actions beyond directing investors to the presentation materials. Glaukos Corporation is a medical device and pharmaceutical company specializing in minimally invasive treatments for glaucoma, keratoconus, and other chronic eye diseases.